by Liliana Resende | Mar 24, 2021 | News
Women under 50 and people who experienced severe disease had worse long-term outcomes following hospitalisation with COVID-19. The first long-term follow-up data from the International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) Clinical...
by Liliana Resende | Mar 10, 2021 | News
In the largest study of its kind to date, the UK’s International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC), supported by the UK Coronavirus Immunology Consortium (UK-CIC), has identified new biomarkers of inflammation that both indicate the...
by Liliana Resende | Feb 15, 2021 | News, Uncategorised
The Lancet Infectious Diseases published the GloPID-R and ISARIC Long COVID Forum Working Group’ letter, describing the content and discussions of the Long COVID Forum which took place on 9-10 December 2020. This global public forum, organised by ISARIC, GloPID-R and...
by Liliana Resende | Jan 18, 2021 | News
The spread of COVID-19 in Brazil overwhelmed the health systems in all the country’s regions, particularly in areas where they were already fragile, according to a collaborative effort involving ISGlobal, an institution supported by the ”la Caixa” Foundation, the...
by Liliana Resende | Jan 18, 2021 | News
ISARIC 4C has developed a new tool to predict a person’s risk of being admitted to hospital and dying from COVID-19, the ISARIC 4C Deterioration model. There is an urgent need for reliable models that predict the likely course of COVID-19, to support decisions...
by Liliana Resende | Jan 18, 2021 | News
Study, co-authored by our member Kenneth Bailie, looking at genetic variants linked to the development of life-threatening illness in patients with COVID-19. Points of interest: It brings understanding as to why some people are at a higher risk of a mild infection...
